Carol Giltner Gallagher, Director at Atara Biotherapeutics, Inc. (ATRA), sold 11,639 shares at $48.78 ($568K) on 2015-08-19, disclosed to the SEC on 2015-08-19.
Scheduled sale ($568k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $49.38 | 5,764 | $285K | 50.1% |
| 2 | $47.98 | 4,375 | $210K | 37.0% |
| 3 | $48.78 | 1,500 | $73K | 12.9% |
| Total | $48.78 avg | 11,639 | $568K | 100% |
| Filing → |
| ATRA | SELL | 2018-06-19 | $112K | — | Filing → |
| ATRA | SELL | 2018-05-16 | $13K | — | Filing → |
| ATRA | SELL | 2018-02-20 | $110K | — | Filing → |